The high methylation level of OPCML observed in sera of some cases in other biliary diseases such as chronic cholecystitis (7/19) and papillary adenoma (5/9) may reflect an increase risk in developing CCA in the future in which clinical follow up of these patients should be concerned. This evidence concerns the gene OPCML and Cholecystitis.